These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 27190045)
21. Relationship between number of ovulatory cycles and accumulation of mutant p53 in epithelial ovarian cancer. Webb PM; Green A; Cummings MC; Purdie DM; Walsh MD; Chenevix-Trench G J Natl Cancer Inst; 1998 Nov; 90(22):1729-34. PubMed ID: 9827528 [TBL] [Abstract][Full Text] [Related]
22. Hormone-related factors and gynecological conditions in relation to endometrial cancer risk. Zucchetto A; Serraino D; Polesel J; Negri E; De Paoli A; Dal Maso L; Montella M; La Vecchia C; Franceschi S; Talamini R Eur J Cancer Prev; 2009 Aug; 18(4):316-21. PubMed ID: 19554665 [TBL] [Abstract][Full Text] [Related]
23. Modification of the Associations Between Duration of Oral Contraceptive Use and Ovarian, Endometrial, Breast, and Colorectal Cancers. Michels KA; Pfeiffer RM; Brinton LA; Trabert B JAMA Oncol; 2018 Apr; 4(4):516-521. PubMed ID: 29346467 [TBL] [Abstract][Full Text] [Related]
24. The epidemiology of ovarian cancer in Greece: a case-control study. Tzonou A; Day NE; Trichopoulos D; Walker A; Saliaraki M; Papapostolou M; Polychronopoulou A Eur J Cancer Clin Oncol; 1984 Aug; 20(8):1045-52. PubMed ID: 6540687 [TBL] [Abstract][Full Text] [Related]
25. Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies. Pfeiffer RM; Park Y; Kreimer AR; Lacey JV; Pee D; Greenlee RT; Buys SS; Hollenbeck A; Rosner B; Gail MH; Hartge P PLoS Med; 2013; 10(7):e1001492. PubMed ID: 23935463 [TBL] [Abstract][Full Text] [Related]
26. Risk reduction of endometrial and ovarian cancer after bisphosphonates use: A meta-analysis. Zhang XS; Zhang YM; Li B; Fan B; Zhao Y; Yang SJ Gynecol Oncol; 2018 Sep; 150(3):509-514. PubMed ID: 29960711 [TBL] [Abstract][Full Text] [Related]
27. An epidemiologic study of ovarian cancer. Part 11: Oral contraceptive use and menstrual events. Badawy YA; Bayoumi DM J Egypt Public Health Assoc; 1992; 67(5-6):579-91. PubMed ID: 1294683 [TBL] [Abstract][Full Text] [Related]
28. The effect of statins on risk and survival of gynecological malignancies. Lavie O; Pinchev M; Rennert HS; Segev Y; Rennert G Gynecol Oncol; 2013 Sep; 130(3):615-9. PubMed ID: 23718932 [TBL] [Abstract][Full Text] [Related]
29. Hypertension and hormone-related neoplasms in women. Soler M; Chatenoud L; Negri E; Parazzini F; Franceschi S; la Vecchia C Hypertension; 1999 Aug; 34(2):320-5. PubMed ID: 10454461 [TBL] [Abstract][Full Text] [Related]
30. Menstrual and reproductive factors and endometrial cancer risk: Results from a population-based case-control study in urban Shanghai. Xu WH; Xiang YB; Ruan ZX; Zheng W; Cheng JR; Dai Q; Gao YT; Shu XO Int J Cancer; 2004 Feb; 108(4):613-9. PubMed ID: 14696129 [TBL] [Abstract][Full Text] [Related]
31. An analysis of the association between statin use and risk of endometrial and ovarian cancers in the Women's Health Initiative. Desai P; Wallace R; Anderson ML; Howard BV; Ray RM; Wu C; Safford M; Martin LW; Rohan T; Manson JE; Simon MS Gynecol Oncol; 2018 Mar; 148(3):540-546. PubMed ID: 29422345 [TBL] [Abstract][Full Text] [Related]
32. The risk of breast and gynecological cancer in women with a diagnosis of infertility: a nationwide population-based study. Lundberg FE; Iliadou AN; Rodriguez-Wallberg K; Gemzell-Danielsson K; Johansson ALV Eur J Epidemiol; 2019 May; 34(5):499-507. PubMed ID: 30623293 [TBL] [Abstract][Full Text] [Related]
33. Endometriosis as a risk factor for ovarian or endometrial cancer - results of a hospital-based case-control study. Burghaus S; Häberle L; Schrauder MG; Heusinger K; Thiel FC; Hein A; Wachter D; Strehl J; Hartmann A; Ekici AB; Renner SP; Beckmann MW; Fasching PA BMC Cancer; 2015 Oct; 15():751. PubMed ID: 26487094 [TBL] [Abstract][Full Text] [Related]
34. Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use. Petitti DB; Porterfield D Contraception; 1992 Feb; 45(2):93-104. PubMed ID: 1559340 [TBL] [Abstract][Full Text] [Related]
35. The effect of bisphosphonates on the risk of endometrial and ovarian malignancies. Rennert G; Rennert HS; Pinchev M; Lavie O Gynecol Oncol; 2014 May; 133(2):309-13. PubMed ID: 24556062 [TBL] [Abstract][Full Text] [Related]
36. Does a family history of cancer increase the risk for postmenopausal endometrial carcinoma? A prospective cohort study and a nested case-control family study of older women. Olson JE; Sellers TA; Anderson KE; Folsom AR Cancer; 1999 Jun; 85(11):2444-9. PubMed ID: 10357416 [TBL] [Abstract][Full Text] [Related]
37. Family history and the risk of endometrial cancer. Parazzini F; La Vecchia C; Moroni S; Chatenoud L; Ricci E Int J Cancer; 1994 Nov; 59(4):460-2. PubMed ID: 7960212 [TBL] [Abstract][Full Text] [Related]
38. The preventable burden of endometrial and ovarian cancers in Australia: A pooled cohort study. Laaksonen MA; Arriaga ME; Canfell K; MacInnis RJ; Byles JE; Banks E; Shaw JE; Mitchell P; Giles GG; Magliano DJ; Gill TK; Klaes E; Velentzis LS; Hirani V; Cumming RG; Vajdic CM Gynecol Oncol; 2019 Jun; 153(3):580-588. PubMed ID: 30935715 [TBL] [Abstract][Full Text] [Related]
39. A prospective study of dietary acrylamide intake and the risk of endometrial, ovarian, and breast cancer. Hogervorst JG; Schouten LJ; Konings EJ; Goldbohm RA; van den Brandt PA Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2304-13. PubMed ID: 18006919 [TBL] [Abstract][Full Text] [Related]
40. Associations of a Healthy Lifestyle Index With the Risks of Endometrial and Ovarian Cancer Among Women in the Women's Health Initiative Study. Arthur R; Brasky TM; Crane TE; Felix AS; Kaunitz AM; Shadyab AH; Qi L; Wassertheil-Smoller S; Rohan TE Am J Epidemiol; 2019 Feb; 188(2):261-273. PubMed ID: 30407487 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]